First-Ever OTC Inspections Drove Surge Of FDA Warning Letters In FY 2019
The good news: 75% of never-before-inspected firms complied with US drug GMP requirements. The bad news: 25% did not.
You may also be interested in...
Action responds to methanol contamination in hand sanitizers manufactured in Mexico and marketed in the US under numerous brands that followed a loosening standards for the products to drive a swift increase in production and meet surging demand during the coronavirus pandemic.
New import alert category and border testing required after reduced standards put dangerous sanitizers into hands of US consumers.
Inadequate process controls and faulty failure investigations were the top GMP violations found in warning letters sent in FY 2019 to companies large and small.